Ligand: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Tuesday reported a third-quarter loss of $15.3 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the San Diego-based company said it had a loss of 81 cents. Earnings, adjusted for non-recurring costs and amortization costs, came to 49 cents per share.
The drugmaker posted revenue of $24.8 million in the period.
Ligand expects full-year earnings in the range of $3 to $3.20 per share, with revenue expected to be $118 million.
Ligand shares have declined 18% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $111.73, a fall of 30% in the last 12 months.